PD-1 BLOCKADE AS AN ADJUNCT THERAPY FOR ART: IMPROVES ANTI-SIV IMMUNITY, VIROLOGIC RESPONSE TO ART AND GUT CD4 T-CELL RESTORATION

被引：0

作者：

Velu, Vijayakumar ^{[1
]}

Mylvaganam, Geetha ^{[1
]}

Freeman, Gordon ^{[2
]}

Ahmed, Rafi ^{[1
]}

Amara, Rama ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

JOURNAL OF MEDICAL PRIMATOLOGY | 2014年 / 43卷 / 05期

关键词：

D O I：

暂无

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

引用

页码：393 / 393

页数：1

共 50 条

[41] Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Kumar, Amrendra
Ramani, Vijay
Bharti, Vijaya
Bellan, Daniel de Lima
Saleh, Nabil
Uzhachenko, Roman
Shen, Chengli
Arteaga, Carlos
Richmond, Ann
Reddy, Sangeetha M.
Vilgelm, Anna
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (05)
[42] Preclinical Characterization of Combinability and Potential Synergy of Anti-CD20/CD3 T-Cell Dependent Bispecific Antibody with Chemotherapy and PD-1/PD-L1 Blockade
Sun, Liping Laura
Wang, Peiyin
Clark, Robyn
Hristopoulos, Maria
Ellerman, Diego
Mathieu, Mary
Chu, Yu-Waye
Wang, Hong
Totpal, Klara
Ebens, Allen J.
Polson, Andrew G.
Gould, Stephen
BLOOD, 2016, 128 (22)
[43] Severely exhausted CD8 T cells are refractory to rescue by PD-1 blockade, but re-invigorate following concomitant CD4 T cell depletion in vivo
Penaloza-MacMaster, Pablo
Barouch, Dan
JOURNAL OF IMMUNOLOGY, 2013, 190
[44] In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized Mice
Palmer, Brent E.
Neff, C. Preston
LeCureux, Jonathan
Ehler, Angelica
DSouza, Michelle
Remling-Mulder, Leila
Korman, Alan J.
Fontenot, Andrew P.
Akkina, Ramesh
JOURNAL OF IMMUNOLOGY, 2013, 190 (01): : 211 - 219
[45] Anti-HER2 CD4 T-cell Immunity Strongly Correlates with Pathologic Complete Response to Neoadjuvant Therapy in HER2+ Breast Cancer
Datta, J.
Xu, S.
Berk, E.
Lowenfeld, L.
Wang, X.
Fitzpatrick, E.
Lewis, D.
Goodman, N.
DeMichele, A.
Czerniecki, B.
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S15 - S15
[46] Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1
Yamaguchi, Ou
Atarashi, Kazuyuki
Yoshimura, Kenichi
Shiono, Ayako
Mouri, Atsuhito
Nishihara, Fuyumi
Miura, Yu
Hashimoto, Kosuke
Miyamoto, Yoshiaki
Uga, Hitoshi
Seki, Nobuo
Matsushima, Tomoko
Kikukawa, Norihiro
Kobayashi, Kunihiko
Kaira, Kyoichi
Kagamu, Hiroshi
BMC CANCER, 2022, 22 (01)
[47] Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1
Ou Yamaguchi
Kazuyuki Atarashi
Kenichi Yoshimura
Ayako Shiono
Atsuhito Mouri
Fuyumi Nishihara
Yu Miura
Kosuke Hashimoto
Yoshiaki Miyamoto
Hitoshi Uga
Nobuo Seki
Tomoko Matsushima
Norihiro Kikukawa
Kunihiko Kobayashi
Kyoichi Kaira
Hiroshi Kagamu
BMC Cancer, 22
[48] Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART
Bui, John K.
Cyktor, Joshua C.
Fyne, Elizabeth
Campellone, Shalyn
Mason, Stephen W.
Mellors, John W.
PLOS ONE, 2019, 14 (01):
[49] Single-Cell Polyfunctional Proteomic Profiling Reveals Temporal and Niche Differences in CD4 and CD8 T Cells in Acute Myeloid Leukemia Following PD-1 Blockade Therapy
Root, Jessica Lynn
Desai, Poonam N.
Reville, Patrick K.
Ly, Christopher
Wang, Bofei
Jelloul, Fatima Z.
Zhou, Jing
Mackay, Sean Gregory
Alfayez, Mansour
Matthews, Jairo
Pierce, Sherry
Daver, Naval
Abbas, Hussein A.
BLOOD, 2023, 142
[50] Peripheral CD4 T cell resistance to type I interferon defines outcome of PD1 blockade therapy in human cancer
Boukhaled, Giselle M.
Gadalla, Ramy
Elsaesser, Heidi J.
Sacher, Adrian
Butler, Marcus O.
Brooks, David G.
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):

← 1 2 3 4 5 →